全文获取类型
收费全文 | 1383篇 |
免费 | 151篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 44篇 |
妇产科学 | 10篇 |
基础医学 | 250篇 |
口腔科学 | 102篇 |
临床医学 | 97篇 |
内科学 | 229篇 |
皮肤病学 | 78篇 |
神经病学 | 213篇 |
特种医学 | 158篇 |
外科学 | 128篇 |
综合类 | 35篇 |
预防医学 | 58篇 |
眼科学 | 12篇 |
药学 | 65篇 |
中国医学 | 2篇 |
肿瘤学 | 65篇 |
出版年
2018年 | 18篇 |
2017年 | 12篇 |
2016年 | 13篇 |
2015年 | 16篇 |
2014年 | 14篇 |
2013年 | 27篇 |
2012年 | 28篇 |
2011年 | 37篇 |
2010年 | 27篇 |
2009年 | 45篇 |
2008年 | 36篇 |
2007年 | 51篇 |
2006年 | 32篇 |
2005年 | 36篇 |
2004年 | 43篇 |
2003年 | 46篇 |
2002年 | 46篇 |
2001年 | 39篇 |
2000年 | 54篇 |
1999年 | 37篇 |
1998年 | 39篇 |
1997年 | 51篇 |
1996年 | 38篇 |
1995年 | 31篇 |
1994年 | 26篇 |
1993年 | 29篇 |
1992年 | 26篇 |
1991年 | 40篇 |
1990年 | 26篇 |
1989年 | 39篇 |
1988年 | 36篇 |
1987年 | 27篇 |
1986年 | 34篇 |
1985年 | 31篇 |
1984年 | 27篇 |
1983年 | 23篇 |
1982年 | 15篇 |
1981年 | 24篇 |
1980年 | 17篇 |
1979年 | 19篇 |
1978年 | 20篇 |
1977年 | 16篇 |
1976年 | 11篇 |
1975年 | 15篇 |
1974年 | 13篇 |
1973年 | 10篇 |
1972年 | 10篇 |
1970年 | 10篇 |
1913年 | 9篇 |
1912年 | 10篇 |
排序方式: 共有1553条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation 总被引:2,自引:1,他引:1
Kapelushnik J; Or R; Filon D; Nagler A; Cividalli G; Aker M; Naparstek E; Slavin S; Oppenheim A 《Blood》1995,86(8):3241-3246
Beta-thalassemia major (TM) is caused by any of approximately 150 mutations within the beta-globin gene. To establish the degree of chimerism after bone marrow transplantation (BMT), we have performed molecular analysis of beta-globin mutations in 14 patients with TM over a period of 10 years. All patients underwent T cell-depleted allogeneic BMT from HLA-identical related donors, using either in vitro T-cell depletion with CAMPATH 1M and complement or in vivo depletion using CAMPATH 1G in the bone marrow collection bag. To date, at different time periods after BMT, seven patients have some degree of chimerism; six of these patients, all blood transfusion-independent, have donor cells in the range of 70% to 95%, with stable mixed chimerism (MC). The seventh patient has less than 10% donor cells with, surprisingly, only minimal transfusion requirements. The detection of beta-globin gene point mutation, as used here, is a highly specific and sensitive marker for engraftment and MC in patients with thalassemia. In light of its specificity, the method is applicable in all cases of TM, as it is independent of sex and other non-globin-related DNA markers. The high incidence of MC found in our patients may be a consequence of the pre- BMT T-cell depletion. Because MC was associated with transfusion independence, complete eradication of residual host cells for effective treatment of TM and possibly other genetic diseases may prove not to be essential. 相似文献
5.
The role of growth factors and cytokines in the impaired healing of chronic leg ulcers remains uncertain. The aim of this study was to determine whether changes in the amount and location of cytokines and growth factors may be associated with impaired healing in chronic leg ulcers. Biopsies from leg ulcers of 21 patients and from normal skin of nine healthy volunteers were examined immunohistochemically for selected growth factors and cytokines. Greater staining intensity was found in keratinocytes at the edges of ulcers compared to normal skin, or skin adjacent to the ulcers. Staining at the ulcer edge was more intense in nonhealing ulcers for only vascular endothelial growth factor and platelet-derived growth factor, whereas staining in the adjacent skin was more intense for all factors in the nonhealing phase. For all factors staining was cytoplasmic, suggesting production in these areas. This study shows up-regulation of the production of cytokines and growth factors in keratinocytes of chronic leg ulcers that is greater when the ulcers are nonhealing. 相似文献
6.
7.
8.
9.
10.
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 总被引:1,自引:0,他引:1
Collins CE Benson MJ Burnham WR Rampton DS 《Alimentary pharmacology & therapeutics》1996,10(3):315-320
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2 has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. METHODS: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. RESULTS: Increased amounts of thromboxane B2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147- 325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61- 140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64- 206), 8). Incubation with picotamide at concentrations between 100 microM and 1 mM reduced thromboxane B2 release (IC50 890 microM). CONCLUSION: Since increased thromboxane A2 production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease. 相似文献